Early Stage Investigator Seed Grants

A key component of the ARLG Mentoring Core is the availability of fellow and Early Stage Investigator (ESI) Seed Grants. Each year, up to $50,000 in direct costs will be provided to up to five ESIs for research in areas related to antibacterial resistance (AR). The purpose of the ESI Seed Grant is to allow researchers to generate preliminary data leading to additional external funding. Researchers who are in the early stages of their career (five years or less) are eligible. ESI Seed Grants can be used to support initial research in any area related to AR. Importantly, these funds can be used to give ESIs access to strains contained in the ARLG Virtual Biorepository Strain Catalogue.

For additional ESI Seed Grant information, please refer to: ARLG ESI GRANT AT A GLANCE v1

The comprehensive proposal application will ask for the following information (if applicable). This will be completed on the website:

  • NIH Biosketch of proposing investigator
  • NIH Biosketch of mentor
  • Letter of support
  • Study rationale
  • Hypothesis
  • Primary objective(s) and endpoint(s) – including primary and secondary (if any) outcome(s)
  • Study centers (proposed)
  • Study population
  • Study design include descriptive research methodology for conducting the study;  your research proposal may be sent as an attachment in Appendix A (should to be no more than 3 pages)
  • Intervention/treatment
  • Sample size estimate
  • Timeline and length of participant follow-up
  • New and/or unique assay
  • External support/collaboration/funding
  • Publication references
  • Estimated costs in $ (direct)

Proposals will be reviewed by the ARLG Executive Committee in the order that they are received.



“My primary mentor has been Vance Fowler, MD, and I have benefited tremendously from his leadership of the ARLG. I think this is the ultimate training ground for an early-career investigator with an interest in clinical trials that can address the crisis of antibacterial resistance.”

Thomas L. Holland, MD, MSc
Duke University

Hear from other ARLG Early Stage Investigators

Apply Now